NCT07542483: A Study of Lebrikizumab in Adults With Nummular Eczema
- State
- Under way
- Phase
- Phase 3
- People
- 270 planned
- Started
- 24 Apr 2026
- Primary completion
- Aug 2028
- Arms
- Placebo-controlled Period: Lebrikizumab, Blinded Extension Period: Lebrikizumab, Blinded Extension Period: Lebrikizumab + Placebo
- Results
- None posted
- 21 Apr 2026: Trial registered
- 24 Apr 2026: Trial started